Log in to save to my catalogue

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid t...

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7992505

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Atypical teratoid/rhabdoid tumors (ATRTs) typically arise in the central nervous system (CNS) of children under 3 years of age. Despite intensive multimodal therapy (surgery, chemotherapy and, if age permits, radiotherapy), median survival is 17 months
1
,
2
. We show that ATRTs robustly express
B7-H3
/
CD276
that does not r...

Alternative Titles

Full title

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7992505

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7992505

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-020-0821-8

How to access this item